These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29383869)

  • 1. Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults.
    Kulkarni AS; Brutsaert EF; Anghel V; Zhang K; Bloomgarden N; Pollak M; Mar JC; Hawkins M; Crandall JP; Barzilai N
    Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29383869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial.
    Kumari S; Bubak MT; Schoenberg HM; Davidyan A; Elliehausen CJ; Kuhn KG; VanWagoner TM; Karaman R; Scofield RH; Miller BF; Konopka AR
    J Gerontol A Biol Sci Med Sci; 2022 Dec; 77(12):2373-2377. PubMed ID: 34865016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin alters skeletal muscle transcriptome adaptations to resistance training in older adults.
    Kulkarni AS; Peck BD; Walton RG; Kern PA; Mar JC; Windham ST; Bamman MM; Barzilai N; Peterson CA
    Aging (Albany NY); 2020 Oct; 12(20):19852-19866. PubMed ID: 33071237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial.
    Walton RG; Dungan CM; Long DE; Tuggle SC; Kosmac K; Peck BD; Bush HM; Villasante Tezanos AG; McGwin G; Windham ST; Ovalle F; Bamman MM; Kern PA; Peterson CA
    Aging Cell; 2019 Dec; 18(6):e13039. PubMed ID: 31557380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin does not compromise energy status in human skeletal muscle at rest or during acute exercise: A randomised, crossover trial.
    Kristensen JM; Lillelund C; Kjøbsted R; Birk JB; Andersen NR; Nybo L; Mellberg K; Balendran A; Richter EA; Wojtaszewski JFP
    Physiol Rep; 2019 Dec; 7(23):e14307. PubMed ID: 31833226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.
    Rasouli N; Kern PA; Elbein SC; Sharma NK; Das SK
    Pharmacogenet Genomics; 2012 Jul; 22(7):484-97. PubMed ID: 22437669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury.
    Gore DC; Wolf SE; Sanford A; Herndon DN; Wolfe RR
    Ann Surg; 2005 Feb; 241(2):334-42. PubMed ID: 15650645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
    Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin to Augment Strength Training Effective Response in Seniors (MASTERS): study protocol for a randomized controlled trial.
    Long DE; Peck BD; Martz JL; Tuggle SC; Bush HM; McGwin G; Kern PA; Bamman MM; Peterson CA
    Trials; 2017 Apr; 18(1):192. PubMed ID: 28441958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.
    Hällsten K; Virtanen KA; Lönnqvist F; Sipilä H; Oksanen A; Viljanen T; Rönnemaa T; Viikari J; Knuuti J; Nuutila P
    Diabetes; 2002 Dec; 51(12):3479-85. PubMed ID: 12453903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.
    Viljanen AP; Virtanen KA; Järvisalo MJ; Hällsten K; Parkkola R; Rönnemaa T; Lönnqvist F; Iozzo P; Ferrannini E; Nuutila P
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6523-8. PubMed ID: 16189256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term exposure to a clinical dose of metformin increases skeletal muscle mitochondrial H
    McKenzie AI; Mahmassani ZS; Petrocelli JJ; de Hart NMMP; Fix DK; Ferrara PJ; LaStayo PC; Marcus RL; Rondina MT; Summers SA; Johnson JM; Trinity JD; Funai K; Drummond MJ
    Exp Gerontol; 2022 Jun; 163():111804. PubMed ID: 35405248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic effects of metformin in skeletal muscle arteries of obese insulin-resistant rats.
    Padilla J; Thorne PK; Martin JS; Rector RS; Akter S; Davis JW; Laughlin MH; Jenkins NT
    Exp Biol Med (Maywood); 2017 Mar; 242(6):617-624. PubMed ID: 28114814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin restores responses to insulin but not to growth hormone in Sprague-Dawley rats.
    Borst SE; Snellen HG; Ross H; Scarpace PJ; Kim YW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):722-6. PubMed ID: 11855850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin treatment affects adipocytokine secretion and lipid composition in adipose tissues of diet-induced insulin-resistant rats.
    Grycel S; Markowski AR; Hady HR; Zabielski P; Kojta I; Imierska M; Górski J; Blachnio-Zabielska AU
    Nutrition; 2019; 63-64():126-133. PubMed ID: 30959381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
    Tripathy D; Daniele G; Fiorentino TV; Perez-Cadena Z; Chavez-Velasquez A; Kamath S; Fanti P; Jenkinson C; Andreozzi F; Federici M; Gastaldelli A; Defronzo RA; Folli F
    Diabetologia; 2013 Oct; 56(10):2153-63. PubMed ID: 23811853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.
    Pernicova I; Kelly S; Ajodha S; Sahdev A; Bestwick JP; Gabrovska P; Akanle O; Ajjan R; Kola B; Stadler M; Fraser W; Christ-Crain M; Grossman AB; Pitzalis C; Korbonits M
    Lancet Diabetes Endocrinol; 2020 Apr; 8(4):278-291. PubMed ID: 32109422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial.
    Snaith JR; Samocha-Bonet D; Evans J; Liu Z; Kowalski G; Bruce C; Holmes-Walker DJ; Greenfield JR
    Diabet Med; 2021 Sep; 38(9):e14564. PubMed ID: 33774848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.